[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100430829":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":33,"locations":42,"responsibleParty":61,"collaborators":64,"id":83,"slug":84,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":89,"eligibilityCriteria":90,"healthyVolunteers":85,"sex":91,"minAge":92,"maxAge":93,"enrollmentInfo":94,"targetDuration":24,"studyType":97,"phases":98,"briefSummary":100,"conditions":101,"keywords":105,"overallStatus":44,"whyStopped":24,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"National Cancer Center, Korea","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Endoscopic treatment arm","ACTIVE_COMPARATOR","Endoscopic submucosal dissection",[13],"Procedure: Endoscopic submucosal dissection",{"label":15,"type":10,"description":16,"interventionNames":17},"Surgical treatment group","Gastrectomy with lymph node dissection",[18],"Procedure: Surgery",[20,25],{"type":21,"name":11,"description":22,"armGroupLabels":23,"otherNames":24},"PROCEDURE","Endoscopic submucosal dissection by a endoscopist using endoscopic devices",[9],null,{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Surgery","Gastrectomy with lymph node dissection by a surgeon",[15],[30],{"name":31,"affiliation":5,"role":32},"Il Ju Choi, MD, PhD","PRINCIPAL_INVESTIGATOR",[34,38],{"name":31,"role":35,"phone":36,"phoneExt":24,"email":37},"CONTACT","+82-31-920-2282","cij1224@ncc.re.kr",{"name":39,"role":35,"phone":40,"phoneExt":24,"email":41},"Young-Il Kim, MD, PhD","+82-31-920-1712","11996@ncc.re.kr",[43],{"facility":5,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":24,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"RECRUITING","Goyang-si","Gyeonggi-do","410-769","South Korea",{"type":50,"coordinates":51},"Point",[52,53],126.835,37.65639,{"lat":53,"lon":52},[56,59],{"name":57,"role":35,"phone":36,"phoneExt":24,"email":58},"Il Ju Choi, M.D., Ph.D.","cij1224@hanmail.net",{"name":60,"role":32,"phone":24,"phoneExt":24,"email":24},"Il Ju Choi, M.D.,Ph.D",{"type":32,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Il Ju Choi","Principal Scientist",[65,68,70,73,75,77,79,81],{"name":66,"class":67},"Seoul St. Mary's Hospital, The Catholic University","UNKNOWN",{"name":69,"class":67},"Chilgok Kyungpook National University Hospital",{"name":71,"class":72},"Pusan National University Hospital","OTHER",{"name":74,"class":72},"Samsung Medical Center",{"name":76,"class":67},"Severance Hospital, Yonsei University College of Medicine",{"name":78,"class":67},"Gangnam Severance Hospital, Yonsei University College of Medicine",{"name":80,"class":72},"Asan Medical Center",{"name":82,"class":72},"Chonnam National University Hospital","100430829","comparison-of-endoscopic-resection-and-surgery-for-early-gastric-cancer-with-undifferentiated-histological-type-100430829",false,"NCT04890171","Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type","Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type: a Multicenter Randomized Controlled Trial (ERASE-GC Trial)","ERASE-GC","Inclusion Criteria:\n\n1. Patients who are diagnosed with undifferentiated type EGC (signet ring cell carcinoma, poorly differentiated tubular adenocarcinoma, or poorly cohesive carcinoma) that meets the expanded indication of ESD 1) Tumor confined to the mucosa without ulcer, and size ≤2 cm on endoscopic evaluations 2) No evidence of lymph node metastasis and distant metastasis on abdominal CT scan\n2. Adult patients aged 19-75 years\n3. Patients who had willingness to sign an informed consent form\n\nExclusion Criteria:\n\n1. Patient age: \\\u003C 19 years or age \\> 75 years\n2. Diagnosis and active treatment for other organ cancer except carcinoma in situ and non-melanomatous skin cancer within 5 years\n3. Previous gastrectomy or esophagectomy history\n4. Multiple gastric cancers\n5. Current treatment for serious medical condition which could hinder study participation including severe heart dysfunction, liver cirrhosis, renal failure, chronic obstructive pulmonary disease or asthma, or uncontrolled infection\n6. Inability to provide an informed consent\n7. Inadequate conditions for study enrollment according to the evaluation of study physicians","ALL","19 Years","75 Years",{"count":95,"type":96},708,"ESTIMATED","INTERVENTIONAL",[99],"NA","This multi-center, randomized controlled trial is designed to evaluate clinical effectiveness and cost-effectiveness of ESD for undifferentiated type of EGC meeting the expanded indication compared with surgery.",[102,103,104],"Stomach Cancer","Undifferentiated Type","Expanded Indication of Endoscopic Resection",[106,11,26,107,108],"Early gastric cancer","Undifferentiated type","Expanded indication","2024-12-25",{"date":111,"type":112},"2024-12-27","ACTUAL",{"date":114,"type":112},"2021-06-11",{"date":116,"type":96},"2029-02-28",{"name":5,"class":6},1]